Weight and Type 2 Diabetes after Bariatric Surgery: Systematic Review and Meta-analysis



      The prevalence of obesity-induced type 2 diabetes mellitus is increasing worldwide. The objective of this review and meta-analysis is to determine the impact of bariatric surgery on type 2 diabetes in association with the procedure performed and the weight reduction achieved.


      The review includes all articles published in English from January 1, 1990, to April 30, 2006.


      The dataset includes 621 studies with 888 treatment arms and 135,246 patients; 103 treatment arms with 3188 patients reported on resolution of diabetes, that is, the resolution of the clinical and laboratory manifestations of type 2 diabetes. Nineteen studies with 43 treatment arms and 11,175 patients reported both weight loss and diabetes resolution separately for the 4070 diabetic patients in these studies. At baseline, the mean age was 40.2 years, body mass index was 47.9 kg/m2, 80% were female, and 10.5% had previous bariatric procedures. Meta-analysis of weight loss overall was 38.5 kg or 55.9% excess body weight loss. Overall, 78.1% of diabetic patients had complete resolution, and diabetes was improved or resolved in 86.6% of patients. Weight loss and diabetes resolution were greatest for patients undergoing biliopancreatic diversion/duodenal switch, followed by gastric bypass, and least for banding procedures. Insulin levels declined significantly postoperatively, as did hemoglobin A1c and fasting glucose values. Weight and diabetes parameters showed little difference at less than 2 years and at 2 years or more.


      The clinical and laboratory manifestations of type 2 diabetes are resolved or improved in the greater majority of patients after bariatric surgery; these responses are more pronounced in procedures associated with a greater percentage of excess body weight loss and is maintained for 2 years or more.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Buchwald H.
        • Avidor Y.
        • Braunwald E.
        • et al.
        Bariatric surgery: a systematic review and meta-analysis.
        JAMA. 2004; 292: 1724-1737
        • Ball C.
        • Sackett D.
        • Phillips B.
        • et al.
        • CEBM website
        Levels of Evidence and Grades of Recommendation.
        (Accessed January 2, 2007)
        • Jadad A.R.
        • Moore R.A.
        • Carroll D.
        • et al.
        Assessing the quality of reports of randomized clinical trials: is blinding necessary?.
        Control Clin Trials. 1996; 17: 1-12
        • Hedges L.
        • Olkin I.
        Random effects models for effect sizes.
        in: Statistical Methods for Metaanalysis. 42. Academic Press, Orlando, FL1985: 191-200
        • DerSimonian R.
        • Laird N.
        Metaanalysis in clinical trials.
        Control Clin Trials. 1986; 7: 177-188
        • Cochran W.G.
        The comparison of percentages in matched samples.
        Biometrika. 1950; 37: 256-266
        • Higgins J.P.T.
        • Thompson S.G.
        Quantifying heterogeneity in a meta-analysis.
        Stat Med. 2002; 21: 1539-1558
        • Mokdad A.H.
        • Ford E.S.
        • Bowman B.A.
        • et al.
        Diabetes trends in the U.S.: 1990-1998.
        Diabetes Care. 2000; 23: 1278-1283
        • Engelgau M.M.
        • Geiss L.S.
        • Saaddine J.B.
        • et al.
        The evolving diabetes burden in the United States.
        Ann Intern Med. 2004; 140: 945-950
        • Cowie C.C.
        • Rust K.F.
        • Byrd-Holt D.D.
        • et al.
        Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002.
        Diabetes Care. 2006; 29: 1263-1268
        • Wild S.
        • Roglic G.
        • Green A.
        • et al.
        Global prevalence of diabetes.
        Diabetes Care. 2004; 27: 1047-1053
        • Hossain P.
        • Kawar B.
        • Nahas M.E.
        Obesity and diabetes in the developing world—a growing challenge.
        N Engl J Med. 2007; 356: 213-215
      1. The World Health Report 2006.
        Geneva World Health Organization, Geneva, Switzerland2006
        • Worldwatch Institute
        Chronic hunger and obesity epidemics eroding global progress.
        (Accessed January 2, 2007)
        • World Health Organization
        The global challenge of obesity, 2002.
        (Accessed January 2, 2007)
        • Flegal K.M.
        • Carol M.D.
        • Kuczmarski R.J.
        • Johnson C.L.
        Overweight and obesity in the United States: prevalence and trends, 1960-1994.
        Int J Obes. 1998; 22: 39-47
        • Mokdad A.H.
        • Ford E.S.
        • Bowman B.A.
        • et al.
        Prevalence of obesity, diabetes and obesity-related health risk factors, 2001.
        JAMA. 2003; 289: 76-79
        • Mokdad A.H.
        • Bowman B.A.
        • Ford E.S.
        • et al.
        The continuing epidemics of obesity and diabetes in the United States.
        JAMA. 2001; 286: 1195-1200
      2. North American Association for the Study of Obesity (NAASO) and the National Heart, Lung, and Blood Institute (NHLBI). The Practical Guide: Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. NIH Publication #00-4084, Oct 2000.

      3. NHANES III Public Use Data File. U.S. Department of Health and Human Services (DHHS). National Center for Health Statistics. Third National Health and Nutrition Examination Survey, 1988-1994, NHANES III Laboratory Data File (CD-ROM). Public Use Data File Documentation Number 76200. Hyattsville, MD: Centers for Disease Control and Prevention, 1996. Available from National Technical Information Service (NTIS), Springfield, VA.

        • Hu F.B.
        • Manson J.E.
        • Stampfer M.J.
        • et al.
        Diet, lifestyle, and the risk of type 2 diabetes mellitus in women.
        N Engl J Med. 2001; 345: 790-797
        • Manson J.E.
        • Willett W.C.
        • Stampfer M.J.
        • et al.
        Body weight and mortality among women.
        N Engl J Med. 1995; 333: 677-685
        • Burstein R.
        • Epstein Y.
        • Charuzi I.
        • et al.
        Glucose utilization in morbidly obese subjects before and after weight loss by gastric bypass operation.
        Int J Obes Relat Metab Disord. 1995; 19: 558-561
        • Abbasi F.
        • Brown Jr, B.W.
        • Lamendola C.
        • et al.
        Relationship between obesity, insulin resistance, and coronary heart disease risk.
        J Am Coll Cardiol. 2002; 40: 937-943
        • National Institutes of Health Consensus Development Panel
        Gastrointestinal surgery for severe obesity.
        Ann Intern Med. 1991; 115: 956-961
        • CDC/NHANES
        Overweight and obesity: Obesity trends: U.S. Obesity Trends 1985-2005.
        (Accessed June 18, 2007)
        • Pories W.J.
        • Swanson M.S.
        • MacDonald K.G.
        • et al.
        Who would have thought it?.
        Ann Surg. 1995; 222: 339-352
        • MacDonald K.G.
        • Long S.D.
        • Swanson M.S.
        • et al.
        The gastric bypass operation reduces the progression and mortality of non-insulin dependent diabetes mellitus.
        J Gastrointest Surg. 1997; 1: 213-220
        • Schauer P.R.
        • Burguera B.
        • Ikramuddin S.
        • et al.
        Effect of laparoscopic Roux-en-Y gastric bypass on Type 2 diabetes mellitus.
        Ann Surg. 2003; 238: 467-484
        • Christou N.V.
        • Sampalis J.S.
        • Liberman M.
        • et al.
        Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients.
        Ann Surg. 2004; 240: 416-423
        • Flum D.R.
        • Dellinger E.P.
        Impact of gastric bypass operation on survival: a population-based analysis.
        J Am Coll Surg. 2004; 199: 543-551
        • Pories W.J.
        • Albrecht R.J.
        Etiology of type II diabetes mellitus: role of the foregut.
        World J Surg. 2001; 25: 527-531
        • Hickey M.S.
        • Pories W.J.
        • MacDonald Jr, K.G.
        • et al.
        A new paradigm for type 2 diabetes mellitus: could it be a disease of the foregut?.
        Ann Surg. 1998; 227: 637-643
        • Gannon M.C.
        • Nuttall F.Q.
        • Lane J.T.
        • et al.
        Effect of 24 hours of starvation on plasma glucose and insulin concentrations in subjects with untreated non-insulin-dependent diabetes mellitus.
        Metab Clin Exp. 1996; 45: 492-497
        • Rubino F.
        • Forgione A.
        • Cummings D.E.
        • et al.
        The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes.
        Ann Surg. 2006; 244: 741-749
        • Arguelles-Sarmiento J.
        • Barnal-Velasquez H.
        • Andujo-Vasquez L.
        • Pories W.J.
        Control of Type 2 diabetes mellitus in non-obese patients with stomach sparing duodeno-jejunal exclusion (SSDJE): report of the first ten cases.
        Surg Obes Related Dis. 2009; (in press)
        • Buchwald H.
        • Estok R.
        • Fahrbach K.
        • Banel D.
        • Sledge I.
        Trends in mortality in bariatric surgery: a systematic review and meta-analysis.
        Surgery. 2007; 142: 621-635
        • Dimick J.B.
        • Welch H.G.
        • Birkmeyer J.D.
        Surgical mortality as an indicator of hospital quality.
        JAMA. 2004; 292: 847-851